Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Pacific Edge Deemed An Essential Provider

Cancer diagnostic company, Pacific Edge, advises that its medical and diagnostic services laboratories in both New Zealand and the USA have been identified as Essential Businesses and that they are operating during the Government-directed COVID-19 shutdowns.

The Pacific Edge laboratories, in New Zealand and the USA, will continue to operate with a full staff of technical and supervisory team members providing Cxbladder analysis services to primary care and secondary care physicians.

The laboratories are controlled access, clean molecular-diagnostic environments and additional safety protocols have been put in place to enhance the operating environment safety for staff providing services in these challenging circumstances. These include two separate operations teams with only one team on site at a time, safe distancing, extra cleaning and sanitisation. Remote working has been enabled for all other employees.

The Company has sufficient laboratory consumables to meet expected demand, with support from its suppliers to ensure ongoing provision of necessary components.

To help reduce the spread of COVID-19, General Practitioners (GPs) in New Zealand have rapidly moved to doing most of their patient consultations by phone, email and video. Pacific Edge is uniquely positioned to support medical practitioners in this challenging time by providing timely evaluation and diagnosis of bladder cancer for their patients in self-isolation at home, with a minimum of face-to-face contact.

CEO of Pacific Edge, David Darling, said: “For many diseases and illnesses, a timely diagnosis can have a significant impact on health outcomes. In this challenging healthcare environment, remote consultations and the ability for patients to supply Cxbladder test samples from home will all help to take the pressure off the healthcare system, while continuing to provide patients with timely and appropriate care.

“This is a rapidly changing situation. We are closely monitoring our customer's needs, the market and the operating environment and we will continue to keep the market updated on any further developments.”

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Reserve Bank: RBNZ To Implement $30bn Large Scale Asset Purchase Programme Of NZ Govt Bonds

The Monetary Policy Committee (MPC) has decided to implement a Large Scale Asset Purchase programme (LSAP) of New Zealand government bonds. The negative economic implications of the coronavirus outbreak have continued to intensify. The Committee ... More>>

ALSO:

Elevate NZ: Venture Fund To Lift Productivity

The Government’s new $300 million venture capital fund - announced in last year’s Budget – is now open for business as the Elevate NZ Venture Fund. Finance Minister Grant Robertson says lifting New Zealand's productivity requires well-functioning ... More>>

ALSO:


COVID-19: Case Confirmed In NZ – Expert Reaction

After spreading across the globe for months, the first case of COVID-19 has been reported in New Zealand. The Ministry of Health says the risk of a community outbreak is low, due to their preparedness and the high awareness of the disease. The Science ... More>>

ALSO:

Agriculture: New Legislation To Boost Organics

New organics legislation will boost consumer confidence and help grow an innovative sector, says Food Safety Minister Damien O’Connor. “The Organics Product Bill, introduced to Parliament this week, aims to increase consumer confidence when purchasing ... More>>

ALSO:

Biodiversity Policy: Misinformation Circulating

Forest & Bird is concerned at misinformation circulating regarding a policy statement aimed at protecting New Zealand’s unique biodiversity. The National Policy Statement for Indigenous Biodiversity is being consulted on by the ... More>>

ALSO: